학술논문
Results from the international, randomized phase 3 study of ibrutinib versus chlorambucil in patients 65 Years and older with treatmentnaïve (TN) CLL/SLL (RESONATE-2TM): 4
Document Type
Academic Journal
Author
Hillmen, P; Tedeschi, A; Barr, P M; Robak, T; Owen, C; Ghia, P; Bairey, O; Bartlett, N L; Li, J; Simpson, D; Grosicki, S; Devereux, S; McCarthy, H; Coutre, S; Quach, H; Gaidano, G; Maslyak, Z; Stevens, D A; Janssens, A; Offner, F; Mayer, J; OʼDwyer, M; Hellmann, A; Schuh, A; Siddiqi, T; Pollack, A; Tam, C S; Suri, D; Zhou, C; Clow, F; Styles, L; James, D F; Kipps, T J; Burger, J A
Source
British Journal of Haematology. Apr 01, 2016 173 Suppl 1:7-7
Subject
Language
English
ISSN
0007-1048